Experimental immune therapy takes on stage IV cancers
NCT ID NCT06296056
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early-stage trial tested a combination of immune cells in 9 people with stage IV solid tumors that had stopped responding to standard treatments. The main goal was to see if the therapy is safe and to check for any signs that it might control the disease. The study is now complete, and results will help decide if further testing is warranted.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- immune cell therapy
- What this could lead to
- If successful, this could point toward a new treatment option for people with advanced solid tumors that have not responded to standard therapies.
- What could go wrong
- This is a very early, small Phase 1 trial with only 9 participants, focused mainly on safety. The treatment may not shrink tumors or improve survival, and side effects are unknown.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTATIC are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Seoul Hospital
Ulaanbaatar, Mongolia
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Fighting cancer wasting: can diet and exercise make olanzapine work better?
- Spinal injection of dual immunotherapy plus chemotherapy targets cancer spread to brain lining
- Could a gene mutation predict immunotherapy success? virtual trial aims to find out
- Genetic blueprint of tumors may guide smarter cancer treatment
- Experimental shot aims to rev up immune system against advanced cancers
- Sharper radiation boost aims to tackle head and neck cancers that return